Market News
Smart Trading. Simplified.
Government Loophole Converts Your IRA/401(k) to Physical Gold
Rollover your 401K to a precious metals IRA and protect yourself & family from inflation. Get the ultimate gold IRA investing guide for free from the #1 Gold IRA Company! Now is the time to roll over your 401k into gold for potentially exponential growth. Leading gold IRA experts will help you use a tax & penalty free loophole the IRS doesn't want you to know about.
Get your free guide and start investing today!
The Bull Case For Innovative Industrial Properties
Investors wanting exposure to the income-generating real estate market – but don’t want to buy or otherwise finance a portfolio of physical properties themselves – can instead buy shares in what is known as a Real Estate Investment Trust, or REIT. REITs are traded on numerous securities exchanges, just like normal stocks and shares, making them […]
Buy Gold & Silver with Your IRA/401(k) Using this IRS Loophole
Rollover your 401K to a precious metals IRA and protect yourself & family from inflation. From the #1 gold IRA Company, This free gold & silver IRA guide will show you how you can roll over your IRA or 401(k) into precious metals. Tax free & penalty-free into an IRA holding using a loophole the IRS doesn't want you to know!
Why Did Cathie Wood Buy Pfizer?
While Cathie Wood has been in the financial investment game since the 1970s, it wasn’t until 2014 with the founding of ARK Invest that her journey to becoming a household name began in earnest. Wood’s bold investments and striking claims about the New York Stock Exchange’s most controversial stocks have cemented her as one of […]
Stock Market Whiz Kid Works 1 Hour a Day. Makes Millions.
He was living with his parents. Two years later he had $5 million to play with - all because of this 1 EXTRA INCOME strategy.
To see how he did it click here.
Is Nvidia Stock A Buy?
Nvidia (NVDA) stock has been on an incredible run of late. The company’s stock has given investors a 1,300% return over the last five years, and its most recent quarterly earnings report just happened to be a record-breaking one too, smashing multiple all-time revenue figures and delivering huge bottom-line profits as well. But the company’s […]
The $62.7 Billion Memory-Saving Market
15.8 million people suffer from Alzheimer's, Parkinson's or ALS. But one little-known biotech is at the forefront revolutionizing this expected $62.7 billion market.
Invest alongside Jeff Bezos, Goldman Sachs, and BlackRock in what The Economist is calling "A Boon to Humanity."
Click here to be a part of it >>>
6 Holiday Stocks to Buy Before Winter
Summer flew by and the holiday season is fast approaching. This is the time when businesses gear up for the make-or-break season of their business. Companies that enjoy a boon in consumer spending over the holiday period often fall under the umbrella of seasonal stocks, ones that move cyclically during the year with somewhat predictable […]
Will there be War with China?
The U.S., China and Russia are rushing to build a strange new weapon. At the center of this new arms race is a small company from Alabama.
Our research proves that anyone who gets in now could profit 8990% >>>
Meet Kevin Running For Governor
Kevin Paffrath (aka Meet Kevin) is a YouTuber and landlord influencer who rose in popularity since going full time on the video sharing site. He regularly livestreams his market trades and provides financial analysis for his nearly 2 million subscribers. When California Governor Gavin Newsom faced a recall election, Paffrath dropped his hat in the […]
Tiny Biotech Creates $2 Trillion Drug
The Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment